| scholarly article | Q13442814 |
| P50 | author | Marja-Riitta Taskinen | Q18246437 |
| Leif Groop | Q27214742 | ||
| Tiinamaija Tuomi | Q29839491 | ||
| Valeriya Lyssenko | Q29839540 | ||
| Bo Isomaa | Q29839548 | ||
| Peter Almgren | Q87790487 | ||
| Carola Saloranta | Q114778686 | ||
| Kaj Lahti | Q114778690 | ||
| P2093 | author name string | Dragi Anevski | |
| Roland Perfekt | |||
| Björn Forsen | |||
| Botnia study group | |||
| Michael Nissén | |||
| Nils Homström | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| preproinsulin | Q7240673 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 166-174 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes | |
| P478 | volume | 54 |
| Q93177055 | 1-Hour Post-OGTT Glucose Improves the Early Prediction of Type 2 Diabetes by Clinical and Metabolic Markers |
| Q44411397 | 1-Hour plasma glucose in obese youth |
| Q40311661 | 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study |
| Q46748191 | 3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, protects against pancreatic β-cells dysfunction induced by high cholesterol |
| Q28542553 | A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetes |
| Q43068410 | A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study |
| Q41922145 | A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control |
| Q35633114 | A randomized controlled exercise training trial on insulin sensitivity in African American men: The ARTIIS study: Major category: study design, statistical design, study protocols. |
| Q33488336 | Actos Now for the prevention of diabetes (ACT NOW) study |
| Q36248046 | Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations |
| Q44798018 | Agreement among type 2 diabetes linkage studies but a poor correlation with results from genome-wide association studies |
| Q28083933 | Alogliptin benzoate for management of type 2 diabetes |
| Q36686234 | Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and type 2 diabetes |
| Q39005596 | Association of New-Onset Diabetes Mellitus in Older People and Mortality in Taiwan: A 10-Year Nationwide Population-Based Study |
| Q33901054 | Association of central adiposity with prediabetes and decreased insulin sensitivity in rural Chinese normal-weight and overweight women |
| Q81557234 | Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus |
| Q25257346 | Authors' Reply |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q38888130 | Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes |
| Q36987314 | Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes |
| Q34721973 | Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial |
| Q30492062 | Cholesterol regulates glucose-stimulated insulin secretion through phosphatidylinositol 4,5-bisphosphate |
| Q35969007 | Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time |
| Q34516146 | Cognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional study |
| Q33610749 | Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy |
| Q33556613 | Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps |
| Q34897184 | Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion |
| Q40280144 | Common variants in HNF-1 alpha and risk of type 2 diabetes |
| Q39416214 | Comparison of normal fasting and one-hour glucose levels as predictors of future diabetes during a 34-year follow-up. |
| Q51467442 | Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia. |
| Q35976403 | Correlates of age onset of type 2 diabetes among relatively young black and white adults in a community: the Bogalusa Heart Study |
| Q34478063 | Cross-tissue and tissue-specific eQTLs: partitioning the heritability of a complex trait |
| Q81382181 | Current literature in diabetes |
| Q37082673 | DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk |
| Q60929186 | Daily Yogurt Consumption Improves Glucose Metabolism and Insulin Sensitivity in Young Nondiabetic Japanese Subjects with Type-2 Diabetes Risk Alleles |
| Q50101181 | Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study). |
| Q33917040 | Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats |
| Q46087673 | Demographic and metabolic characteristics of individuals with progressive glucose tolerance. |
| Q37021969 | Depressive symptoms and metabolic markers of risk for type 2 diabetes in obese adolescents. |
| Q37201691 | Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose |
| Q58102155 | Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia |
| Q34237587 | Diabetes family history: a metabolic storm you should not sit out |
| Q36979951 | Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? |
| Q42875438 | Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis |
| Q38673034 | Early metabolic markers identify potential targets for the prevention of type 2 diabetes |
| Q41689975 | Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults. |
| Q51351064 | Effect of a common variant of the PCSK2 gene on reduced insulin secretion. |
| Q36682071 | Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes |
| Q34017323 | Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study |
| Q35623516 | Electrocardiogram-based sleep spectrogram measures of sleep stability and glucose disposal in sleep disordered breathing |
| Q42193543 | Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study. |
| Q33272514 | Estimation of beta-cell function from the data of the oral glucose tolerance test |
| Q34974105 | Etiology of insulin resistance in youth with type 2 diabetes |
| Q39329664 | Evaluating empirical bounds on complex disease genetic architecture |
| Q39207341 | Exocytosis proteins as novel targets for diabetes prevention and/or remediation? |
| Q33602186 | Familial risks for type 2 diabetes in Sweden |
| Q47255603 | Family history of diabetes and its relationship with insulin secretion and insulin sensitivity in Iraqi immigrants and native Swedes: a population-based cohort study |
| Q51490406 | Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes. |
| Q42972173 | Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus |
| Q89624033 | From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options |
| Q92784035 | Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism |
| Q33604548 | GAD antibody positivity predicts type 2 diabetes in an adult population |
| Q61862494 | Gen-Umwelt-Interaktion in Pathogenese und Prävention des Diabetes mellitus Typ 2 |
| Q81637160 | Genes and type 2 diabetes mellitus |
| Q21563435 | Genetic prediction of future type 2 diabetes |
| Q26829897 | Genetic screening for the risk of type 2 diabetes: worthless or valuable? |
| Q38816589 | Genetics of Type 2 Diabetes: It Matters From Which Parent We Inherit the Risk |
| Q95782022 | Genetics of type 2 diabetes. On overview |
| Q90099874 | Glucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes |
| Q36234353 | Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5. |
| Q36426853 | HbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents. |
| Q57365504 | Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study |
| Q33898833 | High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood--a population based study |
| Q53058978 | High-normal 2 h glucose is associated with defects of insulin secretion and predispose to diabetes in Chinese adults. |
| Q63865935 | Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism |
| Q36604947 | Hypertension and antihypertensive treatment of diabetic nephropathy |
| Q34302041 | ISMRM workshop on fat-water separation: insights, applications and progress in MRI. |
| Q55375158 | Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in s |
| Q38636706 | Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk. |
| Q41634378 | Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution |
| Q36410632 | Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes |
| Q34507211 | Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study |
| Q47120140 | Impaired glucose metabolism in subjects with the Williams-Beuren syndrome: A five-year follow-up cohort study |
| Q35095516 | Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity |
| Q35760283 | Incretin therapy--present and future |
| Q28552106 | Influence of Familial Renal Glycosuria Due to Mutations in the SLC5A2 Gene on Changes in Glucose Tolerance over Time |
| Q45925280 | Influence of childhood parental history of type 2 diabetes on the pre-diabetic and diabetic status in adulthood: the Bogalusa Heart Study. |
| Q52717977 | Insulin Resistance versus β-Cell Failure: Is It Changing in Koreans? |
| Q33941585 | Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase |
| Q34974110 | Insulin resistance in type 2 diabetic youth |
| Q33556896 | Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study |
| Q37634961 | Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. |
| Q53288803 | Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition. |
| Q46581854 | Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. |
| Q26830871 | Interventions to preserve beta-cell function in the management and prevention of type 2 diabetes |
| Q33731708 | Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose? |
| Q36756752 | Isolated hyperglycemia at 1 hour on oral glucose tolerance test in pregnancy resembles gestational diabetes mellitus in predicting postpartum metabolic dysfunction |
| Q40032545 | Joint impact of physical activity and family history on the development of diabetes among urban adults in Mainland China: a pooled analysis of community-based prospective cohort studies. |
| Q46982293 | Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis. |
| Q42167247 | Long-term repeatability of measures of early insulin secretion derived from an intravenous glucose tolerance test and conversion from impaired glucose tolerance to diabetes |
| Q37215500 | Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study |
| Q37144928 | Longitudinal relationships between glycemic status and body mass index in a multiethnic study: evidence from observational and genetic epidemiology |
| Q34332137 | Markers of tissue-specific insulin resistance predict the worsening of hyperglycemia, incident type 2 diabetes and cardiovascular disease |
| Q35916172 | Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes |
| Q46019997 | Men Are from Mars, Women Are from Venus: Sex Differences in Insulin Action and Secretion. |
| Q35620624 | Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China |
| Q36361375 | Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth |
| Q36436985 | Metabolomics in childhood diabetes |
| Q37943855 | Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics |
| Q41483903 | Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery |
| Q51256824 | Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. |
| Q36320847 | Obesity, insulin resistance, and skeletal muscle nitric oxide synthase |
| Q36004565 | Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index |
| Q94600515 | Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure |
| Q37669665 | Pathogenesis, risk assessment and prevention of type 2 diabetes mellitus. |
| Q40003140 | Physical activity, family history of diabetes and risk of developing hyperglycaemia and diabetes among adults in Mainland China. |
| Q24630735 | Physiologic characterization of type 2 diabetes-related loci |
| Q37777010 | Prediabetes: The Importance of Early Identification and Intervention |
| Q42532272 | Prediction of Diabetes Using Serum C-Peptide. |
| Q43494872 | Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. |
| Q33646517 | Public health genomics and genetic test evaluation: the challenge of conducting behavioural research on the utility of lifestyle-genetic tests |
| Q35619020 | Q&A: insulin secretion and type 2 diabetes: why do β-cells fail? |
| Q35132429 | Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes. |
| Q34494927 | Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis |
| Q36971955 | Reproducibility of the oral glucose tolerance test in overweight children |
| Q33790366 | Resting Metabolic Rate Does Not Change in Response to Different Types of Training in Subjects with Type 2 Diabetes |
| Q36990819 | Restoring Mitochondrial Function: A Small Molecule-mediated Approach to Enhance Glucose Stimulated Insulin Secretion in Cholesterol Accumulated Pancreatic beta cells |
| Q30234634 | Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance |
| Q35895869 | Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus |
| Q42241782 | Role of insulin sensitivity and beta cell function in the development of periodontal disease in adults without diabetes |
| Q34479944 | Role of sleep duration in the regulation of glucose metabolism and appetite |
| Q90322636 | Serum vascular adhesion protein-1 is up-regulated in hyperglycemia and is associated with incident diabetes negatively |
| Q35786178 | Sleep and metabolic function |
| Q30481284 | Slow-wave sleep and the risk of type 2 diabetes in humans |
| Q38848879 | Sulforaphane Protects against High Cholesterol-Induced Mitochondrial Bioenergetics Impairments, Inflammation, and Oxidative Stress and Preserves Pancreatic β-Cells Function |
| Q43098902 | TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion |
| Q33283341 | TXNIP regulates peripheral glucose metabolism in humans |
| Q37072688 | The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes |
| Q26997813 | The complex interplay of genetic and lifestyle risk factors in type 2 diabetes: an overview |
| Q34712198 | The emerging genetic architecture of type 2 diabetes |
| Q27002724 | The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases |
| Q39437896 | The metabolic responses induced by acute dexamethasone predict glucose tolerance and insulin secretion over 10 years in relatives of type 2 diabetic subjects |
| Q91589094 | Trajectories of changes in glucose tolerance in a multiethnic cohort of obese youths: an observational prospective analysis |
| Q37304741 | Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. |
| Q33920095 | Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study |
| Q58447602 | Type 2 diabetes mellitus |
| Q37149397 | Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes |
| Q51365759 | Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies. |
| Q37506431 | Weight gain and risk of impaired fasting glucose after smoking cessation |
| Q38241464 | What are the pharmacotherapy options for treating prediabetes? |
| Q80799312 | What for genetics? |
| Q80314156 | Which obesity index best explains prevalence differences in type 2 diabetes mellitus? |
| Q51350644 | XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet-induced obesity. |
| Q35572729 | β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians |
Search more.